major insurance changes are coming to glp 1 drugs GLP-1 for weight loss. Here's how that could affect patients :: WRAL.com Why payers are hesitant to

The new class of weight-loss medications are hailed as game-changing wonder drugs, but just how safe and effective are they

Glucose-dependent insulinotropic polypeptide (GIP) is an intestinal hormone that potentiates glucose-induced insulin secretion in the postprandial state

Helps maintain healthy blood sugar

More recent evidence is expanding their benefits to heart failure with preserved ejection fraction and clinically important renal outcomes in patients with and without diabetes

GIP Receptor Antagonism (Blocking): Unlike many dual-agonists that activate GIP, MariTide blocks it

Wegovy, the GLP-1 medication to treat obesity from Lilly competitor Novo Nordisk, will still be covered under plans managed by CVS Caremark.